BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3921467)

  • 1. Biochemical and clinical evaluation of a new cellulose diacetate secondary filter for cascade filtration.
    Valbonesi M; Tarantino M; Montani F; Florio G; Romorini A
    Int J Artif Organs; 1985 Mar; 8(2):105-8. PubMed ID: 3921467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of fractionation characteristics in cascade filtration.
    Busnach G; Mandelli E; Brando B; Brunati C
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():155-9. PubMed ID: 8013978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenström's type.
    Höffkes HG; Heemann UW; Teschendorf C; Uppenkamp M; Philipp T
    Clin Nephrol; 1995 May; 43(5):335-8. PubMed ID: 7634550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massive hollow fiber clotting: a distinct problem in treatment of cryoglobulinemia by membrane plasmapheresis.
    Lai KN; Cheng SC; Vallance-Owen J
    Artif Organs; 1987 Jun; 11(3):259-64. PubMed ID: 3113406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmapheresis in hyperviscosity syndrome.
    Avnstorp C; Nielsen H; Drachmann O; Hippe E
    Acta Med Scand; 1985; 217(1):133-7. PubMed ID: 3919530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cascade filtration with reverse rinse of the secondary filter.
    Valbonesi M; Lercari G; Angelini G; Malfanti L; Ferrari M; Russo E; Nati S
    J Clin Apher; 1987; 3(4):240-3. PubMed ID: 3119576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmapheresis and cold sensitivity of immunoglobulin molecules. I. A study of hyperviscosity, cryoglobulinemia, euglobulinemia and macroglobulinemia vera.
    Waldenström JG; Raiend U
    Acta Med Scand; 1984; 216(5):449-66. PubMed ID: 6441457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience with plasma exchange: application of an apparatus for plasmapheresis (Haemonetics Model 30) in hyperviscosity syndrome].
    Amamiya Y; Baba M; Hisamitsu J; Ito T; Amaki T
    Rinsho Ketsueki; 1978 Oct; 19(10):1436-8. PubMed ID: 105174
    [No Abstract]   [Full Text] [Related]  

  • 9. [Selective depuration of plasma by filtration. An alternative to plasma exchange].
    Puig LL; Mazzara R; Montesinos A; Gelabert A; Castillo R
    Sangre (Barc); 1988 Apr; 33(2):114-20. PubMed ID: 3135612
    [No Abstract]   [Full Text] [Related]  

  • 10. Different cascade filtration operating modalities in clinical use.
    Busnach G; Dal Col A; Brando B; Cappelleri A; Perrino ML; Brunati C; Minetti L
    Int J Artif Organs; 1988 Nov; 11(6):493-6. PubMed ID: 3144514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical approach to therapeutic apheresis in the management of inflammatory dysimmune polyneuropathies.
    Valbonesi M; Montani F; Mosconi L; Zerbi D; Beltramelli A; Florio G
    Haematologia (Budap); 1985; 18(1):33-43. PubMed ID: 3996945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange].
    Malecaze F; Mathis A; Gonzales C; Lloveras JJ; Goudable C; Arlet P; Bec P
    J Fr Ophtalmol; 1986; 9(5):367-71. PubMed ID: 3100607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based focused review of management of hyperviscosity syndrome.
    Stone MJ; Bogen SA
    Blood; 2012 Mar; 119(10):2205-8. PubMed ID: 22147890
    [No Abstract]   [Full Text] [Related]  

  • 14. Cryoglobulinemia and double-filtration plasmapheresis: Personal experience and literature review.
    Naciri Bennani H; Banza AT; Terrec F; Noble J; Jouve T; Motte L; Malvezzi P; Rostaing L
    Ther Apher Dial; 2023 Feb; 27(1):159-169. PubMed ID: 35583180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cascade filtration: clinical application in 26 patients with immune complex and IgM mediated diseases.
    Valbonesi M; Mosconi L; Montani F; Florio G; Rossi U
    Int J Artif Organs; 1983 Nov; 6(6):303-7. PubMed ID: 6230324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitation of plasmapheresis in cryoglobulinemia with high levels of cryoglobulins.
    Yamashita M; Malchesky PS; Omokawa S; Horiuchi T; Zborowski M; Koo AP; Nosè Y
    Prog Clin Biol Res; 1990; 337():491-4. PubMed ID: 2353010
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic apheresis: when things go wrong.
    Torloni AS; Lumadue J; Zubair A
    J Clin Apher; 2012; 27(3):168-71. PubMed ID: 22504899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic apheresis for the renal complications of multiple myeloma and the dysglobulinemias.
    Kaplan AA
    Ther Apher; 2001 Jun; 5(3):171-5. PubMed ID: 11467752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waldenström's macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia.
    Stone MJ
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):97-9. PubMed ID: 19362986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunomodulation with apheresis technics].
    Liebert A; Quietzsch D; Zimmermann S
    Allerg Immunol (Leipz); 1986; 32(1):5-18. PubMed ID: 2940851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.